Customer Guest
please type the captcha code.
Register|Generate Password|Dos and Don'ts of Demat Account
For Login related queries e-mail: emkayassist@emkayglobal.com
"Attention Investors
1. Stock Brokers can accept securities as margin from clients only by way of pledge in the depository system w.e.f. September 1, 2020. 2. Update your mobile number & email Id with your stock broker/depository participant and receive OTP directly from depository on your email id and/or mobile number to create pledge. 3. Pay 20% upfront margin of the transaction value to trade in cash market segment. 4. Investors may please refer to the Exchange's Frequently Asked Questions (FAQs) issued vide circular reference NSE/INSP/45191 dated July 31, 2020 and NSE/INSP/45534 dated August 31, 2020 and other guidelines issued from time to time in this regard. 5. Check your Securities /MF/ Bonds in the consolidated account statement issued by NSDL/CDSL every month. 6.Investor Charter 7.Disclosure of Complaints 8.COMPLAINTS / SCORES 9. Verify Nomination in Account, click on link (:: Central Depository Services (India) Limited :: )
.......... Issued in the interest of Investors"
Regenerate OTP
Please contact to emkayassist@emkayglobal.com
Please select Mobile No and Email Id for OTP
Login | Register
Login | Register|Forgot password?
Anthem Biosciences Limited hereby informs the exchange of the resignation of Mr. K Ramakrishnan from the position of General Counsel and consequently...more...
Anthem Biosciences Limited has informed the Exchange regarding Resignation of Mr K. Ramakrishnan as Other of the company w.e.f. March 31 2026.more...
Anthem Biosciences Limited hereby informs the Exchange of the First Amendment to the Loan Agreement dated April 15 2024 entered into with Neaonathem ...more...
Anthem Biosciences Limited has informed the Exchange about Transcriptmore...
Earnings Call Transcript for Q3 FY26more...
Anthem Biosciences Limited has informed the Exchange about Copy of Newspaper Publicationmore...
Submission of revised press release for the quarter and nine months ended December 31 2025 in machine readable formatmore...
Submission of Press Release for the Financial Results for the quarter and nine months ended December 31 2025 in machine readable format.more...
Submission of Audio recordings of Earnings Call for the quarter and nine months ended December 31 2025more...
Submission of audio recordings of Earnings Call for the quarter and nine months ended December 31 2025more...
Allotment of 1 03 800 equity shares of face value Rs. 2 each pursuant to the exercise of ESOP Options under Anthem Employee Stock Option Plan 2024more...
The company reported standalone net profit of Rs 112.13 crore for the quarter ended December 31 2025 as compared to Rs 127.99 crore in the s...more...
Submission of revised Press Release for the Financial Results for the quarter and nine months ended December 31 2025 due to inadvertent miss...more...
Revised press release for the financial results for the quarter and nine months ended December 31 2025 due to inadvertent missing out on the complete...more...
Press release for the financial results for the quarter and nine months ended December 31 2025more...
Press release for the financial results for the quarter and nine months ended December 31 2025.more...
Anthem Biosciences Limited has informed the Exchange about Investor Presentationmore...
Submission of Investor Presentation for the quarter and nine months ended December 31 2025more...
Submission of financial results for the quarter and nine months ended December 31 2025more...
BOARD MEETINGS Company Name : Beryl Drugs Date : 01-04-2026